Skip to main content
. 2019 Jan 25;55(1):47–53. doi: 10.4068/cmj.2019.55.1.47

TABLE 1. Criteria of inappropriate treatment according to GOLD guidelines.

graphic file with name cmj-55-47-i001.jpg

GOLD: global initiative for chronic obstructive lung disease, LABA: long acting beta agonist, LAMA: long acting anticholinergics, ICS: inhaled corticosteroids, PDE4: phosphodiesterase 4.